The Impact of Oncotype DX in invasive lobular carcinoma of the breast: An institutional experience

被引：0
|
作者：
McGreevy, Christopher [1 ]
Mateo, Alina [1 ]
De La Cruz, Lucy [1 ]
机构：
[1] Univ Penn, Philadelphia, PA 19104 USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2019年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
581766
引用
收藏
页码：270 / 270
页数：1
相关论文
共 50 条
  • [1] The Impact of Oncotype DX on Adjuvant Chemotherapy for Invasive Lobular Carcinoma
    Deneve, J. L.
    Lee, M. C.
    Joh, J. E.
    Acs, G.
    Khakpour, N.
    Soliman, H.
    Laronga, C.
    Kiluk, J. V.
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 : S76 - S76
  • [2] Is There a Role for Oncotype Dx Testing in Invasive Lobular Carcinoma?
    Conlon, Niamh
    Ross, Dara S.
    Howard, Jane
    Catalano, Jeffrey P.
    Dickler, Maura N.
    Tan, Lee K.
    BREAST JOURNAL, 2015, 21 (05): : 514 - 519
  • [3] Lobular Carcinoma of the Breast and Utility of Oncotype Dx®: a Retrospective Decision Impact Analysis
    Barni, Sandro
    Fabi, Alessandra
    Petrelli, Fausto
    CLINICAL BREAST CANCER, 2022, 23 (03) : E173 - E174
  • [4] Invasive Lobular Carcinoma and Oncotype Dx®: Impact of Pathology and Recurrence Score on Treatment Plan
    Ross, D. S.
    Galman, L. C.
    Catalano, J.
    Tan, L. K.
    MODERN PATHOLOGY, 2012, 25 : 64A - 64A
  • [5] Invasive Lobular Carcinoma and Oncotype Dx®: Impact of Pathology and Recurrence Score on Treatment Plan
    Ross, D. S.
    Galman, L. C.
    Catalano, J.
    Tan, L. K.
    LABORATORY INVESTIGATION, 2012, 92 : 64A - 64A
  • [6] Utility of Oncotype DX Risk Assessment in Patients With Invasive Lobular Carcinoma
    Tsai, Michaela L.
    Lillemoe, Tamera J.
    Finkelstein, Marsha J.
    Money, Joel E.
    Susnik, Barbara
    Grimm, Erin
    Kang, Sung-Hae L.
    Swenson, Karen K.
    CLINICAL BREAST CANCER, 2016, 16 (01) : 45 - 50
  • [7] Can oncotype Dx risk categories be predicted in invasive lobular carcinoma?
    Glasgow, Akisha
    Sechrist, Haley
    Bomeisl, Phillip
    Gilmore, Hannah
    Harbhajanka, Aparna
    CANCER RESEARCH, 2021, 81 (04)
  • [8] Results of Oncotype DX in early-stage invasive lobular carcinoma
    Deneve, J. L.
    Joh, J. E.
    Acs, G.
    Soliman, H. H.
    Khakpour, N.
    Laronga, C.
    Lee, M. C.
    Kiluk, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (27)
  • [9] Utility of Oncotype DX risk assessment in patients with invasive lobular carcinoma (ILC)
    Tsai, Michaela L.
    Money, Joel E.
    Finkelstein, Marsha J.
    Lillemoe, Tamera J.
    Susnik, Barbara
    Grimm, Erin V.
    Kang, Sung-hae L.
    Swenson, Karen K.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (26)
  • [10] Oncotype DX in Invasive Lobular Carcinoma: Higher Recurrence Scores in Unexpected Places
    Limberg, Jessica
    Tao, Alice
    Donahu, Jeannine
    Cristofanilli, Massimo
    Newman, Lisa
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (SUPPL 2) : S527 - S528
12345